Anavex Life Sciences Corp (AVXL)

[falconer66a]

When Blarcemasine Is Approved, ‘CEOChecker’ Will Warn Everyone

Is it any wonder Missling has zero credibility and has dragged Anavex’s reputation into the mud with Wall Street?

When blarcamesine actually gets approved to treat girls suffering from Rett syndrome, it will be informative to watch how a new poster here, ‘CEOChecker,’ will be warning about the hazards of taking or using a drug from a new drug company whose chief executive officer (CEO) has a record of “poor and latent corporate management.”

Watch for this post:

Parents of girls with Rett syndrome don’t be fooled. Yes, so belatedly the FDA has finally approved blarcamesine for Rett syndrome. But, understand, that approval was severely delayed and can’t really be relied upon for either safety or efficacy. The problem is not with the drug, but with the drug company’s CEO — a topic for which I’m an expert. Simply, this fellow took too long to run clinical trials on blarcamesine, and he never reported all the bad stuff about his drug. He fooled the FDA. Don’t be fooled yourself (like a lot of Anavex and blarcamesine supporters on a stock message board were). Bad CEOs make bad drugs, which the FDA approve nonetheless. Don’t let your daughter suffer! The value and safety and efficacy of any and all drugs is determined solely by the speed and accuracy with which drug company CEOs conduct and report their clinical trials — especially to company shareholders. In this regard, Anavex, and its potential customers, are losers. A really bad CEO. Don’t be fooled by the FDA.